PRQR Stock Analysis: Buy, Sell, or Hold?
PRQR - ProQR Therapeutics N.V. Ordinary Shares
$1.62
0.02 (1.25%)
▲
5d:
-7.43%
30d:
-19.0%
90d:
-38.87%
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When PRQR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRQR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRQR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRQR is currently trading at $1.62, which is considered oversold relative to its 30-day fair value range of $1.65 to $2.09.
Technical Outlook: Technically, PRQR is in a downtrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.88 (+447.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRQR is in a downtrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.88 (+447.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.65 -
$2.09
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 447.8% below Wall St target ($8.88)
- CAUTION: Recommendation downgraded due to -7.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.65 -
$2.09
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.58
Resistance Level
$1.80
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.62
Wall Street Target
$8.88
(+447.8%)
Revenue Growth (YoY)
-26.8%
Profit Margin
-264.8%
Last updated: February 02, 2026 6:23 AM ET
Data refreshes hourly during market hours. Next update: 7:23 AM
Data refreshes hourly during market hours. Next update: 7:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRQR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
